Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 1
2007 1
2009 1
2010 1
2015 2
2016 1
2017 1
2019 2
2020 1
2021 2
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
[Nutritional assessment and intervention in hospitalized cancer patients at risk of or with malnutrition: evaluation of the effect on anthropometric and body composition parameters].
Muresan BT, Jiménez-Portilla A, Artero A, Ruiz Berjaga Y, Llamas Montero MDM, Lobo de Mena M, Camps Herrero C, Sánchez Juan C. Muresan BT, et al. Among authors: camps herrero c. Nutr Hosp. 2022 Dec 20;39(6):1316-1324. doi: 10.20960/nh.04219. Nutr Hosp. 2022. PMID: 36454010 Free article. Spanish.
Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer.
Núñez Abad M, Calabuig-Fariñas S, Lobo de Mena M, Torres-Martínez S, García González C, García García JÁ, Iranzo González-Cruz V, Camps Herrero C. Núñez Abad M, et al. Among authors: camps herrero c. Cancers (Basel). 2022 Jan 8;14(2):307. doi: 10.3390/cancers14020307. Cancers (Basel). 2022. PMID: 35053471 Free PMC article. Review.
Capillary and cutaneous hypopigmentation secondary to pazopanib.
Meri-Abad M, Blasco Cordellat A, Camps Herrero C. Meri-Abad M, et al. Among authors: camps herrero c. Med Clin (Barc). 2022 Mar 11;158(5):246-247. doi: 10.1016/j.medcli.2021.05.017. Epub 2021 Jul 3. Med Clin (Barc). 2022. PMID: 34226060 English, Spanish. No abstract available.
Update on systemic treatment in early triple negative breast cancer.
Núñez Abad M, Calabuig-Fariñas S, Lobo de Mena M, José Godes Sanz de Bremond M, García González C, Torres Martínez S, García-García JÁ, Iranzo González-Cruz V, Camps Herrero C. Núñez Abad M, et al. Among authors: camps herrero c. Ther Adv Med Oncol. 2021 Jan 31;13:1758835920986749. doi: 10.1177/1758835920986749. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33613695 Free PMC article. Review.
Long term control stereotactic body radiotherapy (SBRT) for oligometastatic colorectal cancer: a single center study.
Gil-Raga M, Meri-Abad M, Safont Aguilera MJ, Hernández Machancoses A, Lobo M, Calabuig-Fariñas S, López Torrecilla J, Herreros Pomares A, Camps Herrero C. Gil-Raga M, et al. Among authors: camps herrero c. Chin Clin Oncol. 2020 Apr;9(2):13. doi: 10.21037/cco.2020.01.10. Epub 2020 Mar 17. Chin Clin Oncol. 2020. PMID: 32192350 Free article.
A-68-year-old woman with dancing eyes syndrome.
Merí Abad M, Aparisi Aparisi FA, Blasco Cordellat A, Camps Herrero C. Merí Abad M, et al. Among authors: camps herrero c. Med Clin (Barc). 2019 Dec 27;153(12):475. doi: 10.1016/j.medcli.2019.03.012. Epub 2019 Apr 24. Med Clin (Barc). 2019. PMID: 31029373 Free article. English, Spanish. No abstract available.
Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis.
Garde Noguera J, Jantus-Lewintre E, Gil-Raga M, Evgenyeva E, Maciá Escalante S, Llombart-Cussac A, Camps Herrero C. Garde Noguera J, et al. Among authors: camps herrero c. Mol Clin Oncol. 2017 Mar;6(3):403-408. doi: 10.3892/mco.2017.1149. Epub 2017 Feb 3. Mol Clin Oncol. 2017. PMID: 28451421 Free PMC article.
18 results